How to Get Infusion Therapy for Crohn’s Disease or Rheumatoid Arthritis

Picture this: you’ve just left your gastroenterologist’s office after months of unpredictable flares, escalating medication adjustments, and a frank conversation that ends with your doctor saying, “I think it’s time we consider a biologic infusion.” You leave with a pamphlet, a referral, and roughly a thousand unanswered questions. What happens next? Where do I actually go? Will insurance cover this? How long does it take? For patients managing Crohn’s disease infusion therapy or rheumatoid arthritis infusion treatment, that gap between “you need this” and “you’re sitting in the chair” can feel overwhelming, even daunting.

This guide exists to close that gap. We’ve walked alongside hundreds of patients navigating this exact path, and from what I’ve observed working in the infusion space, the process is far more manageable when you know each step before you take it. Below is a practical, plain-language roadmap, from your first specialist conversation to your first infusion appointment, with no steps skipped and no details glossed over.

Step 1: Get a Confirmed Diagnosis and Specialist Referral

Before a single infusion order can be written, the clinical foundation has to be in place. For Crohn’s disease, this means a confirmed inflammatory bowel disease diagnosis from a gastroenterologist, typically supported by colonoscopy findings, imaging, and lab markers. For rheumatoid arthritis, a rheumatologist will establish disease activity through clinical examination, anti-CCP antibody testing, and imaging evidence of joint involvement.

Why Specialist Involvement Matters
A physician-referred infusion center model exists for good reason. Biologic infusions, whether infliximab (Remicade), vedolizumab (Entyvio), ustekinumab (Stelara) for Crohn’s, or tocilizumab (Actemra), abatacept (Orencia), rituximab (Rituxan) for rheumatoid arthritis, are powerful immunomodulating agents. They require precise dosing based on body weight and disease activity, pre-infusion screening for tuberculosis and hepatitis B, and ongoing monitoring for adverse reactions.

Your specialist will determine which biologic is appropriate based on your disease history, prior treatment failures, and comorbidities. In my experience, patients who come to the referral conversation prepared, with a written summary of their symptom history and prior medications, move through this step significantly faster than those who are reconstructing their history from memory.

What to Ask Your Specialist
Which infusion medication is being recommended, and why this one over alternatives? What is the proposed dosing schedule (induction phase versus maintenance)? Which infusion center locations are within your referral network? Will the infusion order and clinical notes be sent directly, or do you need to coordinate the
transfer?

Getting clarity on these questions at the referral stage prevents back-and-forth delays later. Most specialists will send a formal referral order directly to the infusion center, but confirming this workflow with your physician’s office is always worth a phone call.

Step 2: Understand Your Infusion Therapy Insurance Coverage

Infusion therapy insurance coverage is one of the most consequential, and most misunderstood, elements of this process. The good news: most commercial insurance plans, Medicare, and Medicaid cover FDA-approved biologic infusions for Crohn’s disease and rheumatoid arthritis when medical necessity criteria are met. The less straightforward news: coverage terms vary significantly across plans, and prior authorization is almost always required.

How Prior Authorization Works
Prior authorization for infusion therapy is the process by which your insurance company reviews clinical documentation before approving coverage. Your specialist’s office typically initiates this on your behalf, submitting records that demonstrate the following:

• Confirmed diagnosis with supporting objective evidence (labs, imaging, endoscopy reports)
• Documentation of prior treatment attempts and failures (step therapy requirements)
• Clinical justification for the specific biologic requested
• The proposed infusion site (hospital outpatient department versus freestanding infusion center)

Step therapy requirements, sometimes called “fail first” policies, mean insurers may require documented failure of one or more conventional treatments before approving a biologic. For Crohn’s disease, this often means prior trials of corticosteroids, immunomodulators like azathioprine, or 5-ASA agents. For rheumatoid arthritis, it frequently means documented methotrexate failure. Your specialist’s documentation of these prior treatments is critical to a successful authorization.

Site-of-Care Considerations
Where you receive your infusion affects your out-of-pocket costs more than most patients realize. Hospital outpatient infusion departments typically bill at a facility rate that is substantially higher than a freestanding outpatient infusion center. Industry research consistently shows that patients receiving infusions at freestanding outpatient centers, like Thrivewell Infusion, pay meaningfully less in cost-sharing than those treated in a hospital outpatient setting, often without any difference in clinical outcomes or safety monitoring.

Ask your insurer specifically whether your plan has a site-of-care preference or a lower cost-sharing tier for freestanding infusion centers. Many plans actively encourage this shift, and some even require it.

Step 3: Choose the Right Infusion Center for Your Needs

Once your specialist has confirmed the medication and your insurance authorization is underway, you have real input into where you receive treatment. This is a decision worth making deliberately. Outpatient infusion options vary considerably in terms of environment, nurse-to-patient ratios, scheduling flexibility, and the specialization of their clinical staff.

What to Look for in an Infusion Center
For patients managing complex autoimmune conditions, the quality of nursing care is the single most important variable. Infusions like infliximab carry a risk of infusion reactions, particularly during the induction series, and an experienced infusion nurse who recognizes early signs of a reaction and knows how to respond is not interchangeable with general nursing staff. Look for centers that specialize in biologic and specialty drug infusions rather than those that treat infusion as an ancillary service.

Location and scheduling access matter more than patients often anticipate at the outset. Crohn’s disease induction therapy with infliximab, for example, follows a structured infusion schedule that your specialist will determine and adjust based on your response to treatment. Missing or significantly delaying an infusion can compromise treatment efficacy. A center with locations you can realistically reach and flexible appointment availability protects the integrity of your treatment schedule.

Finding an Infusion Center Near You
Thrivewell Infusion operates patient-centered infusion centers across multiple states. Patients searching for an infusion center in New York, an infusion center in New Jersey, or an infusion center in Florida will find Thrivewell locations staffed by registered nurses with specialized experience in biologic infusions for autoimmune conditions. Our centers are designed to feel nothing like a hospital, because for many patients, the infusion chair will be a recurring part of life, and comfort matters.

When evaluating any infusion center, ask these questions directly:

• Does your nursing staff have specific experience with the biologic I’ll be receiving?
• What is your protocol for managing infusion reactions?
• Do you coordinate directly with my specialist for clinical updates?
• What are your available appointment hours, including evenings or weekends?
• Do you assist with specialty pharmacy coordination and drug procurement?

Step 4: Complete Pre-Infusion Requirements and Coordinate Your First Appointment

The period between your referral and your first infusion involves several parallel processes. Understanding what needs to happen, and who is responsible for each piece, prevents the most common source of delay: waiting on something no one knew they were supposed to handle.

Pre-Infusion Screening
Before your first biologic infusion, your specialist or the infusion center’s clinical team will confirm that required screening has been completed. This typically includes:

• Tuberculosis screening: A tuberculin skin test (PPD) or QuantiFERON-TB Gold blood test is required before initiating TNF-alpha inhibitors like infliximab or adalimumab. Biologics that suppress the immune system can reactivate latent TB, making this a non-negotiable safety requirement.
• Hepatitis B serology: Reactivation of hepatitis B is a known risk with several biologics. A hepatitis B surface antigen test and core antibody test are standard pre-treatment requirements.
• Baseline labs: A complete blood count, comprehensive metabolic panel, and in some cases inflammatory markers (CRP, ESR) establish your clinical baseline.
• Vaccinations: Live vaccines cannot be administered once biologic therapy begins. Your specialist may recommend catching up on pneumococcal, influenza, or shingles vaccines before your first infusion.

I’ve seen delays of two to four weeks occur simply because TB screening hadn’t been completed before the insurance authorization was approved. Coordinate with your specialist to start screening as early in the process as possible, ideally before or concurrent with the prior authorization submission.

Specialty Pharmacy and Drug Procurement
Biologic medications are dispensed through specialty pharmacies, not standard retail pharmacies. Your infusion center will typically coordinate this process on your behalf, working with the specialty pharmacy to ensure the medication is available for your scheduled infusion date. Some insurance plans designate a specific specialty pharmacy; your insurer and infusion center can confirm which pharmacy is in-network for your plan.

Manufacturer patient assistance programs, such as the Janssen CarePath program for Remicade, can significantly reduce or eliminate out-of-pocket costs for commercially insured patients who meet eligibility criteria. Ask your infusion center’s benefits coordination team whether you qualify.

Step 5: Prepare for Your First Infusion Day

Your first infusion appointment will include time for pre-infusion screening, the infusion itself, and a period of observation afterward, particularly for induction-dose infusions like infliximab. Your clinical team will manage the structure of subsequent appointments based on how well you
tolerate treatment.

What to Bring and What to Expect
Arrive with your insurance cards, a photo ID, and any co-pay assistance cards or manufacturer program documentation. Wear comfortable, loose-fitting clothing with easy access to the arm or hand where the IV will be placed. Eat normally beforehand unless your clinical team has indicated otherwise. Bring something to occupy your time, whether that’s a laptop, a book, headphones, or a podcast queue. Many infusion centers, including Thrivewell locations, offer Wi-Fi, reclining chairs, and private or semi-private bays to make the time as comfortable as possible.

Your nurse will review your medical history, confirm your current medications for potential interactions, access your IV, and administer a pre-medication (often acetaminophen and an antihistamine) before beginning the infusion. Vital signs are monitored periodically throughout. The goal is a calm, controlled clinical experience, not a rushed procedure.

For patients managing Crohn’s disease infusion therapy long-term, the infusion center becomes a familiar, almost routine part of the treatment rhythm. That transition, from anxiety to familiarity, usually happens faster than most patients expect.

Frequently Asked Questions

1. How long does it take to get approved for biologic infusion therapy? The timeline varies by insurer, but most prior authorizations for biologic infusions are processed within 5 to 15 business days once complete documentation is submitted. Urgent cases can sometimes be expedited. The most common source of delay is incomplete clinical documentation, so thorough submission from your specialist’s office is critical.
2. Can I choose any infusion center, or does my doctor decide? You generally have the right to choose your infusion site, though your insurer’s network and your physician’s referral preferences may influence your options. A physician-referred infusion center arrangement means your doctor initiates the referral, but the final choice of location is typically yours. Always confirm network participation with your insurer before booking.
3. What is the difference between a hospital infusion and an outpatient infusion center? Hospital outpatient departments and freestanding outpatient infusion centers both provide medically supervised infusions, but they differ significantly in cost, environment, and scheduling. Freestanding centers like Thrivewell Infusion typically offer lower cost-sharing for patients, a more comfortable non-clinical setting, and more flexible scheduling, making them the preferred choice for many patients on long-term maintenance therapy.
4. Does insurance cover infusion therapy for Crohn’s disease and rheumatoid arthritis? Yes. Infusion therapy insurance coverage for FDA-approved biologics used in Crohn’s disease and rheumatoid arthritis is standard across most commercial plans, Medicare Part B, and many Medicaid programs, provided medical necessity criteria are satisfied. The prior authorization process exists to confirm those criteria. Out-of-pocket costs depend on your specific plan and the infusion site you choose.
5. What should I do if my prior authorization is denied? A denial is not final. Most denials can be appealed with additional clinical documentation, a letter of medical necessity from your specialist, or a peer-to-peer review between your physician and the insurance company’s medical reviewer. Your specialist’s office and your infusion center’s patient services team can help navigate this process. Many denials are overturned on first appeal.
6. Are there infusion centers that specialize in autoimmune conditions like Crohn’s and RA? Yes. Thrivewell Infusion centers specialize in biologic and specialty infusions for autoimmune and inflammatory conditions, including Crohn’s disease and rheumatoid arthritis. Our nursing staff has experience with the full range of currently available biologics for these conditions. Patients looking for an infusion center in New York, New Jersey, or Florida can find a Thrivewell location near them.

Key Takeaways

• Start with your specialist. A confirmed diagnosis and a physician referral are the foundation of the entire process. Bring a thorough symptom and medication history to accelerate this step.
• Prior authorization is expected, not exceptional. Nearly every biologic infusion requires prior authorization for infusion therapy. Work with your specialist’s office to ensure documentation is complete and submitted promptly.
• Site of care affects your costs. Freestanding outpatient infusion centers consistently offer lower patient cost-sharing than hospital outpatient departments for the same medications and the same standard of care.
• Pre-infusion screening takes time. Start TB and hepatitis B screening as early as possible, ideally concurrent with the insurance authorization process, to avoid delays.
• You have options. Whether you’re searching for an infusion center in New Jersey, New York, Florida, or beyond, Thrivewell Infusion offers specialized, patient-centered care for Crohn’s disease and rheumatoid arthritis infusion therapy.
• Manufacturer assistance programs can reduce costs significantly. Ask your infusion center’s benefits team about co-pay support programs before your first appointment.